Epithelioid Sarcoma Natural History Study

计划入组 74 人 · 首次发布于 2019 年 2 月 12 日

An Observational Study on Epithelioid Sarcoma

计划入组 100 人 · 首次发布于 2017 年 4 月 4 日

Tazemetostat Expanded Access Program for Adults With Epithelioid Sarcoma

首次发布于 2020 年 1 月 13 日

Tazemetostat(Tazverik)

C₃₄H₄₄N₄O₄

Sarcoma(Diakonos)

Sarcoma(Arpeggio Biosciences)

Italian Sarcoma Group

Italy

Sarcoma Oncology Research Center LLC

United States

Sarc

United States

Comprehensive Treatment Strategies for Epithelioid Sarcoma: From Frontline Approaches to Disease Progression Management

Eisai's Tazemetostat Receives Orphan Drug Designation in Japan for Rare Epithelioid Sarcoma

Storm Therapeutics Secures $56M Series C to Advance First-in-Class METTL3 Inhibitor STC-15 in Phase II Sarcoma Trial